Abstract
The randomised controlled trial of antipsychotic reduction and discontinuation addresses essential questions with regard to continued use of antipsychotics in schizophrenia, pertaining to social functioning and continued antipsychotic use. However, significant methodological issues stated in the trial protocol have the potential to confound interpretation of any findings. These include use of a non-blinded outcome measure, treatment as usual comparator and possible sample size issues.
| Original language | English |
|---|---|
| Pages (from-to) | 378-380 |
| Number of pages | 3 |
| Journal | Journal of Psychopharmacology |
| Volume | 37 |
| Issue number | 4 |
| Early online date | 12 Jan 2023 |
| DOIs | |
| Publication status | Published - Apr 2023 |